Inflammatory Biomarker and Response to Antidepressant in Major Depressive Disorder: a Systematic Review and Meta-Analysis

Name: Inflammatory Biomarker and Response to Antidepressant in Major Depressive Disorder: a Systematic Review and Meta-Analysis
SKU: 25017
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 52 No. 1 Articles 2022 Tags: antidepressant response, Bellini A, Callegari C, Caselli I, cytokines, Gasparini A, Ielmini M, inflammation, inflammatory biomarker, Lucca G, major-depressive-disorder

Description

Description

Evidence-Based Medicine

Inflammatory Biomarker and Response to Antidepressant in Major Depressive Disorder: a Systematic Review and Meta-Analysis

By Gasparini A, Callegari C, Lucca G, Bellini A, Caselli I, Ielmini M

Inflammatory Biomarker and Response to Antidepressant in Major Depressive Disorder: a Systematic Review and Meta-Analysis

Description

Evidence-Based Medicine

Antipsychotics Case Study by Yuan-Hwa Chou

Trazodone for Depressed Mood, Anxiety, Insomnia, and Suicidality

Gregory M. Asnis, MD: IFN-Induced Depression: A Role for NSAIDs

Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Inflammatory Biomarker and Response to Antidepressant in Major Depressive Disorder: a Systematic Review and Meta-Analysis

Description

Evidence-Based Medicine

Related products

Antipsychotics Case Study by Yuan-Hwa Chou

Trazodone for Depressed Mood, Anxiety, Insomnia, and Suicidality

Gregory M. Asnis, MD: IFN-Induced Depression: A Role for NSAIDs

Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial